Global Vocal Biomarker Market Bwc20123

Global Vocal Biomarker Market By Type (Frequency, Amplitude, Error Rate, Voice Rise/fall time, Phonation Time, Voice Tremor, Pitch and Others), By Indications (Depression, Attention Deficit and Disruptive Behavior Disorders and Others), By Neurological disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory and Cardiovascular Disorders, Traumatic Brain Injury), By End-user (Hospitals and Clinics, Academic and Research, Others); Trend Analysis, Market Competition Scenario & Outlook, 2021-2026

  • Published Date: August 2020
  • Report ID: BWC20123
  • Available Format: PDF
  • Page: 169

Report Overview

Global Vocal Biomarker Market size- Industry Trends & Outlook Report 2026


The Global Vocal Biomarker Market size is estimated at USD 1.73 billion in 2019, and it is expected to reach USD 4.2 billion at a CAGR of 13.6 % during projection period 2020-2026. The market for Vocal Biomarker (a device to detect diseases by speech characteristics) is dependent on the prevalence of psychological, neurological and other diseases affecting speech and the urgency of detection of the severe illness. Besides, its cost efficiency and early detection of diseases drive the market growth. The market has been growing at a steady rate over the past few years. And, it is expected to grow extensively during the projection period. The pharmaceutical companies are exploring the potential of the market further as they help in healthcare and drug sales. The defence and security agencies increasingly use it as a lie-detector test.


Global Vocal Biomarker Market Overview


Recent discoveries in the medical sector have led to the development of an exceptional diagnostic tool known as a vocal biomarker, by linking the concept of biological markers with the vocal pattern to analyze personality traits. Vocal Biomarker is a new medical device used to detect diseases based on voice pattern. It is a cost-efficient and minimally invasive technique which helps detect illnesses in the initial stage. Vocal Biomarker finds application in detection of diseases as well as in the detection of liar suspects. Besides medical practices, it is used by defence organizations and security agencies while probing a defendant. It serves as a substitute for MRI, X-Ray and CT scan in some medical urgency. The advanced uses of this technique are likely to promote its market during the projected period.


Global Vocal Biomarker Market Outlook and Trends


Growth drivers 


Prevalence of Parkinson's Disease and other diseases induce the demand for Vocal Biomarker


As per a study of Parkinson's Foundation, more than 10 million across the globe suffer from Parkinson's disease. The prevalence, risk, early detection requirement and increasing cases of this disease lead to the more demand for vocal Biomarker, assuring strong growth potential for the market. Besides, the rising incidence of traumatic brain injury, cardiovascular & psychological diseases and respiratory disorders will also drive the market during the projection period. 


Growing Applications in Healthcare and Other fields


The vocal biomarkers are finding their application in remote health monitoring of the heart-patient, in the testing voice of the patient with coronary artery disease and recognizing depression and stress among callers besides early detection of diseases in healthcare and lie-detection in security agencies. Such applications are expected to amplify the market for vocal biomarkers.




Accuracy Issues restrict the market growth. 


The accuracy of the vocal Biomarker may vary with the use of complex words and the environments of speech recording. Also, collection, processing and analysis of speech data raise doubts related to its quality. Besides, the inability to extract the desired vocal features, significant errors in the vocal features and inaccuracies of boundaries of words also restrict the use of vocal Biomarker, hampering its growth of the market. 


Impact of COVID-19 in industry


The overall slowdown has been registered in economic activities across the globe. However, people in every sector have learned to maintain social distancing and to work remotely. The vocal Biomarker serves as a remote sensor for patients with fatal diseases and helps to recognize a medical emergency. In COVID times, its application is more relevant and is being deployed in different countries for different medical purposes.


Global Vocal Biomarker Market: Segmentation


The Vocal Biomarker market is segmented into four categories viz., Type, Indications, Neurological Disorders and End-user. The Type category is divided into Frequency, Amplitude, Error Rate, Voice Rise/fall time, Phonation Time, Voice Tremor, Pitch and Others. The Indication category is subdivided into Depression, Attention Deficit and Disruptive Behavior Disorders and Others.


The Neurological Diseases Category is again divided into Parkinson's Disease, Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, Traumatic Brain Injury and Others. The end-user category consists of Hospitals and Clinics, Academic and Research, Others.


In the first category based on type, the voice tremor segment is expected to register significant growth due to rising neurological disorders and growing application of vocal Biomarker in it. In indication category of various diseases, the respiratory diseases segment is anticipated to witness significant growth on account of the prevalence of respiratory diseases and ongoing research on the use of biomarkers in asthma conditions. In the end-user segment, the healthcare sector is likely to observe more applications and more usage of vocal Biomarker during the projection period.


Global Vocal Biomarker Market: Regional Insights 

North America is characterized by well-established healthcare facilities and technological advancements, so it is likely to dominate the Global Vocal Biomarker Market during the projection period. Besides, easy medical reimbursement policies and increasing healthcare expenditure in the region contribute to the growth of the market. Europe is the second most promising market driven by increasing healthcare outlay and rising income & awareness. Asia Pacific region is expected to register growth driven by the markets in China, India, Japan and South Korea. The Middle East and Africa region is anticipated to register the lowest growth on account of technological impediments and poor economic and political conditions.


Competitive landscape


The technological advancements are instilling fierce competition among existing players in Global Vocal Biomarker Market. They are keen on acquiring new technologies, including AI, to improve their market share. The leading players in this market are Sonde Health(US), Beyond Verbal (Israel), IBM Corporation (US), Cogito Corporation (US), Boston Technology Corporation, Microtest Health and others. 


Recent Developments


August 3, 2020: Sonde Health develops a workplace safety tool with voice biometrics. Facial recognition, temperature recognition, wearable and voice biometrics are being deployed COVID-19 spread prevention across the world.

December 12, 2019: Israeli health tech firms- Beyond Verbal and Healthymize merge to advance AI-powered vocal biomarkers. 


Scope of the Report



Years Considered

Historical data – 2016-2019

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South Korea UAE, South Africa, Saudi Arabia.

Product/Service Segmentation

By Type, Indications, Neurological Disorders and End User

Key Players

Sonde Health(US), Beyond Verbal (Israel), IBM Corporation (US), Cogito Corporation (US), Boston Technology Corporation, Microtest Health

By Type

Ø  Frequency

Ø  Amplitude

Ø  Error Rate

Ø  Voice Rise/fall time

Ø  Phonation Time

Ø  Voice Tremor

Ø  Pitch

Ø  Others

By Indications

Ø  Depression

Ø  Attention Deficit 

Ø  Disruptive Behavior Disorders

Ø  Others

By Neurological Disorders

Ø  Parkinsons Disease

Ø  Alzheimer’s Disease

Ø  Huntington’s Disease

Ø  Respiratory and Cardiovascular Disorders

Ø  Traumatic Brain Injury

By End-use

Ø  Hospitals and Clinics

Ø  Academic and Research

Ø  Others

By Region:

Ø  North America

Ø  Europe

Ø  Asia Pacific

Ø  Latin America

Ø  Middle East & Africa


The objective of the Study:


Ø  To analyze and estimate the Global Vocal Biomarker Market size, in terms of value.

Ø  To examine the market segmentation carefully and estimate the market size, in terms of value, based on the region by segmenting the Global Vocal Biomarker Market into five regions, namely, North America, Europe, Asia Pacific, Rest of the World and their leading countries.

Ø  To outline, categorize and project the Global Vocal Biomarker Market based on the By Type, Indications, Neurological Disorders and End User.

Ø  To examine competitive developments in application areas, technology and diverse industry usage within the Global Vocal Biomarker Market.

Ø  To highlight market dynamics such as drivers, restraints, opportunities, and challenges and their impact.

Ø  To provide a detailed competitive landscape, including major players, their strategic profiles, and market shares.


Business Questions Answered by the Report:


Ø  How will the market drivers, restraints, and opportunities affect the market dynamics?

Ø  What will be the market size in terms of value and volume and market statistics with a detailed classification?

Ø  Which segment dominates the market or region, and which one will be the fastest-growing, and why?

Ø  Who are the key players in the market, and what is their share?

Ø  What is the strategy adopted by key players, and how does it affect the existing and new players?


Customization Scope for the Client:


Client satisfaction is our first and last priority, and that is why BlueWeave Consulting offers customization as per client’s specific needs. The following customization options are available for the report:

Ø  Additional Company Information

Ø  Detail Analysis of five additional companies

Ø  Additional country analysis

Ø  Detailed segment analysis